Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
The importance of individually customized treatment for CLL patients
When should we start treatment for relapsed multiple myeloma patients?
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Mathias J Rummel
Graft versus host disease: how to treat it?